NEW YORK (GenomeWeb News) – Clarient Diagnostic Services today said that it has licensed worldwide rights from Insight Genetics to intellectual property covering the anaplastic lymphoma kinase biomarker.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.